Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Extended-release formulations in epilepsy.

Alberto Verrotti1, Carmela Salladini, Giovanna Di Marco

  • 1Department of Medicine, Section of Pediatrics, University of Chieti, Italy. averrott@unich.it

Journal of Child Neurology
|July 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comparison of the efficacy of two different desmopressin formulations in pediatric patients with nocturnal enuresis: a retrospective observational study.

Central European journal of urology·2026
Same author

Effects of White Noise on Academic Skills in Children with ADHD and Specific Learning Disorders: New Perspectives for Personalised Rehabilitation and Educational Intervention.

Pediatric reports·2026
Same author

Childhood absence epilepsy and developmental coordination disorder: an intriguing comorbidity.

Seizure·2026
Same author

Soticlestat for drug-resistant epilepsy: Current evidence and clinical perspectives.

Seizure·2026
Same author

A tiered decisional framework for genetic epileptic syndromes with or without encephalopathies: from standard care to investigational strategies.

Expert review of clinical pharmacology·2026
Same author

Efficacy and safety of continuous midazolam infusion in the treatment of acute repetitive seizures in non-intensive settings: A multicenter retrospective real-world data study.

Epilepsia·2026

Extended-release antiepileptic drugs like valproic acid, carbamazepine, and phenytoin show promising efficacy and tolerability for epilepsy treatment. Further large-scale studies are recommended to confirm these findings.

Area of Science:

  • Pharmacology
  • Pharmaceutical Chemistry
  • Clinical Pharmacy

Background:

  • Extended-release (ER) antiepileptic drug (AED) formulations have been developed and approved for epilepsy management.
  • Key ER AEDs include valproic acid, carbamazepine, and phenytoin.
  • These formulations aim to improve therapeutic outcomes and patient compliance.

Purpose of the Study:

  • To review the chemical and structural characteristics of ER formulations of valproic acid, carbamazepine, and phenytoin.
  • To analyze the bioequivalence data for these ER AEDs.
  • To evaluate the existing clinical use studies of these ER formulations.

Main Methods:

  • Literature review of chemical and structural properties.
  • Analysis of bioequivalence studies.

Related Experiment Videos

  • Synthesis of findings from clinical use investigations.

    • Main Results:

    • Encouraging results regarding the tolerability and efficacy of ER formulations.
    • Bioequivalence data supports the consistent drug release profiles.
    • Clinical studies indicate positive patient outcomes.

    Conclusions:

    • ER formulations of valproic acid, carbamazepine, and phenytoin demonstrate good tolerability and efficacy.
    • Current evidence is promising, but larger clinical trials are necessary.
    • ER AEDs represent a valuable advancement in epilepsy treatment.